Mark J Alles's Net Worth

$28.5 Million

Estimate Recalculated Nov 5, 2024 07:09PM EST

Who is Mark J Alles

Mark J Alles has an estimated net worth of $28.5 Million. This is based on reported shares across multiple companies, which include Turning Point Therapeutics, Inc., BIOMARIN PHARMACEUTICAL INC, Syros Pharmaceuticals, Inc., and CELGENE CORP /DE/.

SEC CIK

Mark J Alles's CIK is 0001538897

Past Insider Trading and Trends

2015 was Mark J Alles's most active year for acquiring shares with 44 total transactions. Mark J Alles's most active month to acquire stocks was the month of January. 2015 was Mark J Alles's most active year for disposing of shares, totalling 42 transactions. Mark J Alles's most active month to dispose stocks was the month of January. 2013 saw Mark J Alles paying a total of $6,330,262.96 for 199,471 shares, this is the most they've acquired in one year. In 2013 Mark J Alles cashed out on 244,966 shares for a total of $16,397,873.10, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Turning Point Therapeutics, Inc.

Investor
Updated Aug 17, 2022
Form 4
-100.00%
-19.21K
$76.00
-$152.00K
Aug 17, 2022
Disposition
Aug 17
Form 4
2.00K
$81.34
$162.68K
Jun 21, 2021
2.00K
Purchase
Jun 21
Form 4
209.00
Jun 04, 2021
209.00
Grant
Jun 02
Form 4
17.00K
May 26, 2021
17.00K
Grant
May 24
Form 3
May 26, 2021
Showing 5 results

BIOMARIN PHARMACEUTICAL INC

Investor
Updated May 24, 2023
Form 4
38.42%
4.19K
May 24, 2023
15.10K
Grant
May 23
Form 4
49.79%
3.63K
$86.75
$314.47K
Nov 02, 2022
10.91K
Purchase
Oct 31
Form 4
216.52%
4.98K
May 26, 2022
7.28K
Grant
May 24
Form 4
2.30K
Jan 05, 2022
2.30K
Grant
Jan 03
Form 3
Jan 05, 2022
Showing 5 results

Syros Pharmaceuticals, Inc.

Investor
Updated Sep 19, 2023
Form 4
Sep 19, 2023
9.00K
Options
Sep 16
Form 4
10.00K
Jun 02, 2023
10.00K
Grant
Jun 01
Form 4
20.00K
Sep 19, 2022
20.00K
Grant
Sep 16
Form 4
17.50K
Jun 02, 2022
17.50K
Grant
Jun 01
Form 4
17.50K
Jun 10, 2021
17.50K
Grant
Jun 08
Form 4
17.50K
Jun 11, 2020
17.50K
Grant
Jun 11
Form 4
10.00K
$8.86
$88.59K
May 13, 2020
10.00K
Purchase
May 13
Form 4
35.00K
Dec 20, 2019
35.00K
Grant
Dec 19
Form 3
Dec 20, 2019
Showing 9 results

CELGENE CORP /DE/

CEO, CHAIRMAN OF BOARD
Updated Nov 22, 2019
Form 4
-100.00%
-534.33K
Nov 22, 2019
Disposition
Nov 20
Form 4
-100.00%
-554.33K
Nov 22, 2019
Disposition
Nov 20
Form 4
-2.90%
-6.62K
$95.21
-$630.29K
May 06, 2019
227.52K
Options
May 02
Form 4
45.03%
101.86K
$85.96
-$1.19M
Mar 05, 2019
334.09K
Options
Mar 01
Form 4
18.80K
Feb 06, 2019
18.80K
Grant
Feb 04
Form 4
33.81K
Jan 30, 2019
33.81K
Grant
Jan 28
Form 4
-1.98%
-3.88K
$68.20
-$264.34K
Dec 18, 2018
198.43K
Options
Dec 16
Form 4
59.23K
Oct 31, 2018
59.23K
Grant
Oct 29
Form 4
59.23K
Aug 01, 2018
59.23K
Grant
Jul 30
Form 4
48.64%
90.52K
$82.60
$99.78K
May 17, 2018
282.69K
Purchase
May 08 - May 09
Form 4
-0.81%
-1.52K
$86.89
-$131.99K
May 08, 2018
192.16K
Options
May 04
Form 4
-1.11%
-2.06K
$95.26
-$196.24K
Feb 20, 2018
190.05K
Options
Feb 17
Form 4
7.28K
Feb 15, 2018
7.28K
Grant
Feb 13
Form 4
1.86%
3.26K
$91.90
$299.59K
Feb 08, 2018
184.83K
Purchase
Feb 08
Form 4
33.88K
Jan 31, 2018
33.88K
Grant
Jan 29
Form 4
-1.18%
-2.09K
$107.06
-$224.18K
Dec 20, 2017
181.57K
Options
Dec 19
Form 4
33.88K
Oct 31, 2017
33.88K
Grant
Oct 30
Form 4
18.24%
31.95K
$134.10
-$259.08K
Aug 01, 2017
212.99K
Options
Jul 28 - Jul 31
Form 4
51.01K
May 02, 2017
51.01K
Grant
May 01
Form 4
4.78%
7.80K
$117.02
-$777.36K
Feb 16, 2017
176.69K
Grant
Feb 14
Form 4
29.67K
Jan 31, 2017
29.67K
Grant
Jan 30
Form 4
-1.82%
-3.02K
$117.63
-$355.01K
Dec 06, 2016
168.89K
Options
Dec 02
Form 4
29.67K
Nov 02, 2016
29.67K
Grant
Oct 31
Form 4
29.67K
Aug 01, 2016
29.67K
Grant
Aug 01
Form 4
24.43%
40.22K
$103.41
-$523.46K
May 03, 2016
210.63K
Options
Apr 29 - May 02
Form 4
9.99%
13.95K
$102.45
-$1.22M
Feb 16, 2016
159.28K
Grant
Feb 12
Form 4
6.06%
8.63K
$27.51
$603.59K
Feb 02, 2016
156.65K
Options
Jan 29 - Feb 01
Form 4
2.64%
3.56K
$112.17
-$602.35K
Dec 18, 2015
143.99K
Options
Dec 16 - Dec 17
Form 4
8.63K
Nov 10, 2015
8.63K
Grant
Nov 09
Form 4
8.63K
Jul 29, 2015
8.63K
Grant
Jul 27
Form 4
5.98%
6.97K
$108.06
-$556.94K
May 04, 2015
129.21K
Options
Apr 30 - May 04
Form 4
-3.72%
-4.08K
$121.53
-$495.60K
Mar 03, 2015
111.04K
Options
Mar 01
Form 4
$45.43
$1.25M
Feb 17, 2015
234.35K
Options
Feb 12
Form 4
-30.50%
-100.36K
$81.12
-$11.25M
Feb 10, 2015
234.18K
Sale
Scheduled
Feb 06
Form 4
10.18K
Feb 04, 2015
10.18K
Grant
Feb 02
Form 4
20.22K
Dec 23, 2014
20.22K
Grant
Dec 19
Form 4
10.18K
Oct 29, 2014
10.18K
Grant
Oct 27
Form 4
24.55K
Jul 29, 2014
24.55K
Grant
Jul 28
Form 4
33.78%
8.35K
$160.54
-$1.10M
Feb 14, 2014
35.69K
Grant
Feb 12
Form 4
11.82K
Feb 05, 2014
11.83K
Grant
Feb 03
Form 4
-12.41%
-3.50K
$168.93
-$591.42K
Dec 31, 2013
27.33K
Options
Dec 27
Form 4
16.41K
Dec 04, 2013
16.41K
Grant
Dec 02
Form 4
-18.05%
-4.50K
$151.31
-$681.18K
Nov 05, 2013
23.06K
Options
Nov 01
Form 4
11.82K
Oct 28, 2013
11.83K
Grant
Oct 28
Form 4
-64.15%
-101.41K
$101.90
-$8.57M
Aug 02, 2013
59.29K
Sale
Jul 31 - Aug 02
Form 4
11.82K
Jul 31, 2013
11.83K
Grant
Jul 29
Form 4
17.32K
May 01, 2013
17.33K
Grant
Apr 29
Form 4
-26.58%
-1.79K
$123.00
-$220.29K
Apr 16, 2013
7.56K
Options
Apr 13
Form 4
8.32K
Jan 30, 2013
8.33K
Grant
Jan 28
Form 4
23.34K
Dec 19, 2012
23.34K
Grant
Dec 17
Form 4
8.32K
Nov 02, 2012
8.33K
Grant
Oct 31
Form 4
8.32K
Aug 01, 2012
8.33K
Grant
Jul 30
Form 4
13.93K
May 01, 2012
13.93K
Grant
Apr 30
Form 4
-29.52%
-902.00
$78.32
-$70.64K
Apr 17, 2012
4.56K
Options
Apr 14
Form 4
16.67K
Mar 07, 2012
16.67K
Grant
Mar 01
Form 3
Feb 24, 2012
2.41K
Showing 56 results